I have been sitting on the sidelines for a while, but
I have been sitting on the sidelines for a while, but paying attention to the board here and there. Figure that today's news is a worthwhile time to ponder out load and post some brain droppings:
Last year IPIX first indicated that they were in talks with parties interested in B-OM. Then it evolved into the August non-binding term sheet for B-OM AND IBD indications. Given that IBD indications is a broad spectrum which includes UP/UC, I cant help but think that the new term sheet, now specifically for UP/UC, indicates that the potential partner is a different company. Because I just cant see why the first potential partner would drop B-OM and IBD indications and re-sign a new sheet just for UP/UC with later options of the irst right of refusal for the other IBD indications. Plus I dont recall the August announcements indicating a Global pharma company as the group for the first term sheet. (I think I may just be recalling that incorrectly, so if someone can confirm or deny that I'd appreciate it. I dont have the time to go do the research just for the sake of this post. I have a day job that doesn't include being paid to troll SMBs.)
Regardless, it seems logical to me that this new sheet is with a new partner and poses a few scenarios:
1) The offer with this new partner is better than the first term sheet for B-OM with the IBD indications as an adder. So IPIX is going after a more lucrative deal.
2) This negates the B-OM term sheet since IBD is now off the table. Which either allows IPIX to have more leverage with potential B-OM partner for a better deal. Leaves IPIX to negotiate B-OM on its own with other suitors. Or the expected upfront money will allow IPIX to keep going it alone with B-OM to progress the trails and make the asset even more valuable.
3) IPIX has two term sheets and two potential partners for the specified indications.
I am sure that reality is likely way different then my musings, but at least we know that another significant concrete step has been made by IPIX on the road to success.
I cant wait for more news to develop!!!!!! Still holding long and strong on this one!!!! (oh and I convinced my brother in-law to by some thousands of shares down in the .10's. So he's stoked about the news too.)
2
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...
Continue Reading
Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...
Continue Reading
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...
Continue Reading
Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...
Continue Reading
In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
Top 5 Most Recently Viewed Articles
Revolutionizing Cultivated Meat Production through Collaboration Stämm has recently announced an exciting collaboration with SuperMeat to accelerate developments in cultivated meat biomanufacturing. With Varana Capital's strategic backing, this partnership seeks to enhance SuperMeat's cultivated chicken production process using Stämm's innovative bioreactor...
Continue Reading
Manchester United Reports Its Fourth Quarter Results Manchester United PLC (NYSE: MANU) has recently released its fiscal fourth-quarter results for 2024. The numbers show a significant year-on-year sales drop of 15.0%, totaling 142.2 million British pounds, or about $179.43 million. Unfortunately, this result didn't meet analysts' expectations, which had projected sales...
Continue Reading
China's Rural Road Achievements and Future Vision Recently, the State Council Information Office of China unveiled an insightful white paper titled "China's Rural Roads in the New Era." This document highlights the incredible accomplishments and future aspirations concerning rural road development in the country. The white paper reveals that by the end of 2023, China's...
Continue Reading
Overview of Fourth Quarter Results Tyson Foods, Inc. (NYSE: TSN), recognized as one of the largest food companies in the world, has showcased impressive financial performance for the fourth quarter of 2025. The company reported sales of $13,860 million, marking a 2.2% increase compared to the corresponding quarter in the previous year. When excluding legal contingency...
Continue Reading
Good Cheer Captures the Victory in Kentucky Oaks Excitement filled the air as Good Cheer claimed a notable victory in the Longines Kentucky Oaks, a highlight of the horse racing calendar. This remarkable race saw Good Cheer emerge victorious in a challenging environment with sloppy track conditions, competing against a strong field of 13 fillies. Record-Worthy Wagering at...
Continue Reading